Glepaglutide

DB14794InvestigationalProtein Based Therapies

Glepaglutide is under investigation in clinical trial NCT00868660 (Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose).

Mechanism: Pharmacologically active on Glucagon-like peptide 2 receptor
Curator reviewed
Code names: ZP1848

Resolves to

Compound

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Glepaglutide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.